IMPIX ALIF S/A, REF number B15241415; intervertebral fusion device - lumbar
FDA Device Recall #Z-2454-2023 — Class II — July 12, 2023
Recall Summary
| Recall Number | Z-2454-2023 |
| Classification | Class II — Moderate risk |
| Date Initiated | July 12, 2023 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Medicrea International |
| Location | Rillieux La Pape, N/A |
| Product Type | Devices |
| Quantity | 5 units |
Product Description
IMPIX ALIF S/A, REF number B15241415; intervertebral fusion device - lumbar
Reason for Recall
There is a potential for a product packaging non-conformity issue which presents as a pinhole in either the inner or outer pouch.
Distribution Pattern
US nationwide
Lot / Code Information
GTIN 03613720264439, Lot Numbers: 18I0824, 19L0046
Other Recalls from Medicrea International
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1039-2026 | Class II | Medicrea, IB3D PL Instruments Set, Rx Only REF... | Oct 29, 2025 |
| Z-1038-2026 | Class II | Medicrea, IB3D Universal Implant Inserter, Rx O... | Oct 29, 2025 |
| Z-1118-2025 | Class II | UNiD" Adaptive Spine Intelligence UNiD Spine... | Dec 3, 2024 |
| Z-2456-2023 | Class II | IMPIX MANTA, REF numbers: a) A20150407, b)... | Jul 12, 2023 |
| Z-2461-2023 | Class II | IMPIX S, REF numbers: a) B15328071S, b) B1... | Jul 12, 2023 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.